| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.9B | $2.6B | $0.2B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.5B | $1.2B | $1.2B | $1.1B | $0.5B | $0.4B | $0.5B | — |
| Net Income | $1.0B | $0.8B | $0.9B | $0.6B | $0.4B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $5.91 | $4.38 | $4.91 | $3.72 | $4.43 | $0.64 | $0.96 | $1.05 |
| EPS (Diluted) | $5.90 | $4.37 | $4.91 | $3.72 | $4.42 | $0.64 | $0.96 | $1.05 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $84.1B | $79.0B | $74.9B | $71.3B | $34.9B | $32.6B | $30.4B | $27.6B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $74.6B | $69.9B | $66.3B | $63.2B | $31.5B | $29.4B | $27.2B | $24.7B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $9.5B | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $1.4B | $1.0B | $1.3B | $0.7B | $0.4B | $0.3B | $0.5B |
| Investing Cash Flow | $-4.7B | $-3.9B | $-2.6B | $-7.2B | $-2.4B | $-2.3B | $-2.5B | $-1.4B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $4.1B | $2.8B | $2.5B | $6.2B | $1.9B | $1.9B | $2.2B | $0.9B |